Survival of motor neurone protein is required for normal postnatal development of the spleen

Journal of Anatomy

Volumn 230, Issue 2, 2017, Pages 337-346

  Thomson, Alison K ^a,b   Somers, Eilidh ^b,c   Powis, Rachael A ^b,c   Shorrock, Hannah K ^b,c   Murphy, Kelley ^d   Swoboda, Kathryn J ^e   Gillingwater, Thomas H ^b,c   Parson, Simon H ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Euan MacDonald Centre for Motor Neuron Disease Research   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d MORGAN STATE UNIVERSITY   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

immunity; megakaryocytes; organ pathology; patients; SMN

Indexed keywords

SURVIVAL MOTOR NEURON PROTEIN; SMN2 PROTEIN, MOUSE; SURVIVAL MOTOR NEURON PROTEIN 2;

ACCESSORY SPLEEN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; B LYMPHOCYTE; CELL DEATH; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INFANT; MOUSE; MOUSE MODEL; NONHUMAN; POSTNATAL DEVELOPMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SPINAL MUSCULAR ATROPHY; SPLEEN; SPLEEN DEFECT; SPLEEN SIZE; ANIMAL; CYTOLOGY; DEFICIENCY; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NEWBORN; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; CELL PROLIFERATION; HUMANS; MICE; MICE, TRANSGENIC; MUSCULAR ATROPHY, SPINAL; SPLEEN; SURVIVAL OF MOTOR NEURON 2 PROTEIN;

EID: 84991038022     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/joa.12546     Document Type: Article

References (48)

1. Araujo A, Araujo M, Swoboda KJ (2009) Vascular perfusion abnormalities in infants with spinal muscular atrophy. J Pediatr 155, 292–294.
2. Bowerman M, Swoboda KJ, Michalski JP, et al. (2012) Glucose metabolism and pancreatic defects in spinal muscular atrophy. Ann Neurol 72, 256–268.
3. Bronte V, Pittet MJ (2013) The spleen in local and systemic regulation of immunity. Immunity 39, 806–818.
4. Cardiff RD, Miller CH, Munn RJ (2014) Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb Protoc 2014, 655–658.
5. Cesta MF (2006) Normal structure, function, and histology of the spleen. Toxicol Pathol 34, 455–465.
6. Crivellato E, Nico B, Ribatti D (2007) Contribution of endothelial cells to organogenesis: a modern reappraisal of an old Aristotelian concept. J Anat 211, 415–427.
7. Czompoly T, Labadi A, Kellermayer Z, et al. (2011) Transcription factor Nk2–3 controls the vascular identity and lymphocyte homing in the spleen. J Immunol 186, 6981–6989.
8. Dachs E, Hereu M, Piedrafita L, et al. (2011) Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy. J Neuropathol Exp Neurol 70, 444–461.
9. Forster R, Schubel A, Breitfeld D, et al. (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23–33.
10. Franke K, Kalucka J, Mamlouk S, et al. (2013) HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis. Blood 121, 1436–1445.
11. Hamilton G, Gillingwater TH (2013) Spinal muscular atrophy: going beyond the motor neuron. Trends Mol Med 19, 40–50.
12. Hsieh-Li HM, Chang JG, Jong YJ, et al. (2000) A mouse model for spinal muscular atrophy. Nat Genet 24, 66–70.
13. Hunter G, Aghamaleky Sarvestany A, Roche SL, et al. (2014) SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy. Hum Mol Genet 23, 2235–2250.
14. Hunter G, Powis RA, Jones RA, et al. (2016) Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy. Hum Mol Genet. DOI: 10.1093/hmg/ddw141 (Ahead of print).
15. Ito Y, Kumada S, Uchiyama A, et al. (2004) Thalamic lesions in a long-surviving child with spinal muscular atrophy type I: MRI and EEG findings. Brain Dev 26, 53–56.
16. Junqueira LC, Bignolas G, Brentani RR (1979) Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11, 447–455.
17. Kim CH (2010) Homeostatic and pathogenic extramedullary hematopoiesis. J Blood Med 1, 13–19.
18. Le Campion A, Bourgeois C, Lambolez F, et al. (2002) Naive T cells proliferate strongly in neonatal mice in response to self-peptide/self-MHC complexes. Proc Natl Acad Sci U S A 99, 4538–4543.
19. Lee M, Kiefel H, LaJevic MD, et al. (2014) Transcriptional programs of lymphoid tissue capillary and high endothelium reveal control mechanisms for lymphocyte homing. Nat Immunol 15, 982–995.
20. Loder F, Mutschler B, Ray RJ, et al. (1999) B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med 190, 75–89.
21. Martínez-Hernández R, Soler-Botija C, Also E, et al. (2009) The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation. J Neuropathol Exp Neurol 68, 474–481.
22. Mayhew TM, Sharma AK (1984) Sampling schemes for estimating nerve fibre size. I. Methods for nerve trunks of mixed fascicularity. J Anat, 139 (Pt 1), 45–58.
23. Mebius RE, Kraal G (2005) Structure and function of the spleen. Nat Rev Immunol 5, 606–616.
24. Monani UR, Lorson CL, Parsons DW, et al. (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 8, 1177–1183.
25. –/– mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet 9, 333–339.
26. Mutsaers CA, Wishart TM, Lamont DJ, et al. (2011) Reversible molecular pathology of skeletal muscle in spinal muscular atrophy. Hum Mol Genet 20, 4334–4344.
27. Myers RC, King RG, Carter RH, et al. (2013) Lymphotoxin α1β2 expression on B cells is required for follicular dendritic cell activation during the germinal center response. Eur J Immunol 43, 348–359.
28. Neely HR, Flajnik MF (2015) CXCL13 responsiveness but not CXCR5 expression by late transitional B cells initiates splenic white pulp formation. J Immunol 194, 2616–2623.
29. Nolte MA, Hamann A, Kraal G, et al. (2002) The strict regulation of lymphocyte migration to splenic white pulp does not involve common homing receptors. Immunology 106, 299–307.
30. Ottesen EW, Howell MD, Singh NN, et al. (2016) Severe impairment of male reproductive organ development in a low SMN expressing mouse model of spinal muscular atrophy. Sci Rep 6, 20193.
31. Powis RA, Gillingwater TH (2016) Selective loss of alpha motor neurons with sparing of gamma motor neurons and spinal cord cholinergic neurons in a mouse model of spinal muscular atrophy. J Anat 228, 443–451.
32. Ramasamy SK, Kusumbe AP, Adams RH (2015) Regulation of tissue morphogenesis by endothelial cell-derived signals. Trends Cell Biol 25, 148–157.
33. Riessland M, Ackermann B, Forster A, et al. (2010) SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Hum Mol Genet 19, 1492–1506.
34. Rindt H, Feng Z, Mazzasette C, et al. (2015) Astrocytes influence the severity of spinal muscular atrophy. Hum Mol Genet 24, 4094–4102.
35. Rudnik-Schoneborn S, Heller R, Berg C, et al. (2008) Congenital heart disease is a feature of severe infantile spinal muscular atrophy. J Med Genet 45, 635–638.
36. Rudnik-Schoneborn S, Vogelgesang S, Armbrust S, et al. (2010) Digital necroses and vascular thrombosis in severe spinal muscular atrophy. Muscle Nerve 42, 144–147.
37. Schreml J, Riessland M, Paterno M, et al. (2013) Severe SMA mice show organ impairment that cannot be rescued by therapy with the HDACi JNJ-26481585. Eur J Hum Genet 21, 643–652.
38. Shababi M, Habibi J, Yang HT, et al. (2010) Cardiac defects contribute to the pathology of spinal muscular atrophy models. Hum Mol Genet 19, 4059–4071.
39. Shababi M, Lorson CL, Rudnik-Schoneborn SS (2014) Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease? J Anat. 224, 15–28.
40. −/− SMN2) genetic mouse model of spinal muscular atrophy. J Pathol 219, 52–60.
41. Sintusek P, Catapano F, Angkathunkayul N, et al. (2016) Histopathological defects in intestine in severe spinal muscular atrophy mice are improved by systemic antisense oligonucleotide treatment. PLoS One 11, e0155032.
42. Somers E, Stencel Z, Wishart TM, et al. (2012) Density, calibre and ramification of muscle capillaries are altered in a mouse model of severe spinal muscular atrophy. Neuromuscul Disord 22, 435–442.
43. Somers E, Lees RD, Hoban K, et al. (2016) Vascular defects and spinal cord hypoxia in spinal muscular atrophy. Ann Neurol 79, 217–230.
44. Sugarman EA, Nagan N, Zhu H, et al. (2012) Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur J Hum Genet 20, 27–32.
45. Terada N, Saitoh Y, Saitoh S, et al. (2010) Visualization of microvascular blood flow in mouse kidney and spleen by quantum dot injection with ‘in vivo cryotechnique’. Microvasc Res 80, 491–498.
46. Wang X, Cho B, Suzuki K, et al. (2011) Follicular dendritic cells help establish follicle identity and promote B cell retention in germinal centers. J Exp Med 208, 2497–2510.
47. Wishart TM, Huang JP-W, Murray LM, et al. (2010) SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy. Hum Mol Genet 19, 4216–4228.
48. Wishart TM, Mutsaers CA, Riessland M, et al. (2014) Dysregulation of ubiquitin homeostasis and beta-catenin signaling promote spinal muscular atrophy. J Clin Invest 124, 1821–1834.